Yale University researcher Akiko Iwasaki, Ph.D., says immune profiling shows how Long COVID patients have distinct features not found in control groups. These patients, who also exhibit elevated levels of exhausted T-cells, cause her to express surprise at skeptics.
Iwasaki joins Fiona Lowenstein, editor of “The Long COVID Survival Guide,” to discuss patients who say they’re suffering from Long COVID for as much as two years after their acute phase of the disease.
Iwasaki also explains why her lab’s effort to move forward with a COVID nasal spray faces financial hurdles.
Listen in to this important conversation with hosts Mark Masselli and Margaret Flinter.
Podcast: Play in new window | Download
Subscribe: Apple Podcasts | Spotify | Android | Podchaser | TuneIn | RSS | More
Originally broadcast April 17, 2025 The U.S. healthcare system could save up to 500,000 lives…
Originally broadcast April 10, 2025 Eccentric billionaire Howard Hughes founded his eponymous Medical Institute over…
Originally broadcast April 3, 2025 Roughly 85% of respondents to a survey cited by Michael…
Originally broadcast March 27, 2025 Two young innovators are leading a movement that proves food…
Originally broadcast March 20, 2025 Mary Bono has left the halls of Congress, but she’s…
Originally broadcast March 13, 2025 Emmy award-winning actor Michael J. Fox shocked the world when…